The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating RSPO2 activation and its association with outcomes and potential role as a driver in double-negative prostate cancer (DNPC).
 
Aiden Deacon
No Relationships to Disclose
 
Ava Gustafson
Employment - Mayo Clinic (I)
 
Ella Boytim
Consulting or Advisory Role - Astrin Biosciences; Tempus
 
David Moline
Stock and Other Ownership Interests - Regeneron (I)
Consulting or Advisory Role - Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - Tempus
 
Elin Kairies
Employment - Lisbon Mt Vernon Ambulance Service
Stock and Other Ownership Interests - Summit Orthopedicts (I)
 
Sam Kellen
No Relationships to Disclose
 
Allison Makovec
No Relationships to Disclose
 
Alexis Anike
No Relationships to Disclose
 
Megan Ludwig
No Relationships to Disclose
 
Justin Drake
Employment - Astrin Biosciences
Leadership - Astrin Biosciences
Stock and Other Ownership Interests - Astrin Biosciences
Consulting or Advisory Role - Astrin Biosciences
Research Funding - Astrin Biosciences
Patents, Royalties, Other Intellectual Property - Royalty from work done supported by a research sponsored grant from Astrin Biosciences
 
Emmanuel Antonarakis
Consulting or Advisory Role - AADi; AIkido Pharma; Amgen; AstraZeneca; Bayer (Inst); Blue Earth Diagnostics; Corcept Therapeutics; Curium Pharma; Foundation Medicine; Hookipa Pharma; Janssen Biotech; Lilly; Menarini Silicon Biosystems; Merck; Pfizer; Sanofi; Tango Therapeutics; Tempus; Z-Alpha
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Merck (Inst); Orion Health (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
 
Justin Hwang
Consulting or Advisory Role - Astrin Bio; Tempus
Research Funding - Astrin Biosciences